PSTV vs. ARTV

Last updated Apr 1, 2026

Compare and contrast key facts about Plus Therapeutics Inc (PSTV) and Artiva Biotherapeutics, Inc (ARTV).

Performance

PSTV vs. ARTV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Plus Therapeutics Inc (PSTV) and Artiva Biotherapeutics, Inc (ARTV). The values are adjusted to include any dividend payments, if applicable.

PSTV vs. ARTV - Yearly Performance Comparison

	2026 (YTD)	2025	2024
PSTV Plus Therapeutics Inc	-68.26%	-55.45%	-33.91%
ARTV Artiva Biotherapeutics, Inc	50.12%	-57.44%	-16.00%

Fundamentals

EPS PSTV : -$0.00 ARTV : -$2.96
Total Revenue (TTM) PSTV : $0.00 ARTV : $0.00
Gross Profit (TTM) PSTV : $0.00 ARTV : -$662.00K
EBITDA (TTM) PSTV : $0.00 ARTV : -$82.23M

Returns By Period

In the year-to-date period, PSTV achieves a -68.26% return, which is significantly lower than ARTV's 50.12% return.

PSTV

• 1D: -24.23%
• 1M: -46.28%
• YTD: -68.26%
• 6M: -76.22%
• 1Y: -82.89%
• 3Y*: -66.56%
• 5Y*: -66.21%
• 10Y*: -69.69%

ARTV

• 1D: 18.17%
• 1M: 10.65%
• YTD: 50.12%
• 6M: 124.39%
• 1Y: 114.67%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

PSTV vs. ARTV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PSTV

PSTV Risk / Return Rank: 13
PSTV Sharpe Ratio Rank: 19
PSTV Sortino Ratio Rank: 19
PSTV Omega Ratio Rank: 20
PSTV Calmar Ratio Rank: 0
PSTV Martin Ratio Rank: 8

ARTV

ARTV Risk / Return Rank: 75
ARTV Sharpe Ratio Rank: 62
ARTV Sortino Ratio Rank: 87
ARTV Omega Ratio Rank: 84
ARTV Calmar Ratio Rank: 75
ARTV Martin Ratio Rank: 69

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PSTV vs. ARTV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Plus Therapeutics Inc (PSTV) and Artiva Biotherapeutics, Inc (ARTV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PSTV	ARTV	Difference
Sharpe ratio Return per unit of total volatility	-0.51	0.60	-1.11
Sortino ratio Return per unit of downside risk	-0.48	2.57	-3.05
Omega ratio Gain probability vs. loss probability	0.94	1.33	-0.38
Calmar ratio Return relative to maximum drawdown	-1.02	1.87	-2.89
Martin ratio Return relative to average drawdown	-1.55	3.28	-4.83
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PSTV vs. ARTV - Sharpe Ratio Comparison

The current PSTV Sharpe Ratio is -0.51, which is lower than the ARTV Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of PSTV and ARTV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	PSTV	ARTV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.51	0.60	-1.11
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.34	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.38	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.35	-0.19	-0.16

Correlation

The correlation between PSTV and ARTV is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

PSTV vs. ARTV - Dividend Comparison

Neither PSTV nor ARTV has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

PSTV vs. ARTV - Drawdown Comparison

The maximum PSTV drawdown since its inception was -100.00%, which is greater than ARTV's maximum drawdown of -90.71%. Use the drawdown chart below to compare losses from any high point for PSTV and ARTV.

Drawdown Indicators

	PSTV	ARTV	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-90.71%	-9.29%
Max Drawdown (1Y) Largest decline over 1 year	-84.06%	-55.59%	-28.47%
Max Drawdown (5Y) Largest decline over 5 years	-99.62%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-100.00%	—	—
Current Drawdown Current decline from peak	-100.00%	-59.32%	-40.68%
Average Drawdown Average peak-to-trough decline	-79.35%	-60.12%	-19.23%
Ulcer Index Depth and duration of drawdowns from previous peaks	55.56%	31.62%	+23.94%

Volatility

PSTV vs. ARTV - Volatility Comparison

Plus Therapeutics Inc (PSTV) has a higher volatility of 34.29% compared to Artiva Biotherapeutics, Inc (ARTV) at 32.12%. This indicates that PSTV's price experiences larger fluctuations and is considered to be riskier than ARTV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PSTV	ARTV	Difference
Volatility (1M) Calculated over the trailing 1-month period	34.29%	32.12%	+2.17%
Volatility (6M) Calculated over the trailing 6-month period	83.69%	126.64%	-42.95%
Volatility (1Y) Calculated over the trailing 1-year period	164.00%	191.08%	-27.08%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	197.12%	160.89%	+36.23%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	184.35%	160.89%	+23.46%

Financials